0.35 USD
↘ 0.01 (2.74%)PRE MARKET (AS OF 04:22 AM EST)
Caribou Biosciences, Inc. Common Stock (CRBU) trades at $0.35 per share. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Strong Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, CRBU appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 13, 2026.